Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to $435001.0.

  • HealthLynked's Cash from Financing Activities fell 5052.47% to $435001.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 4090.9%. This contributed to the annual value of $2.9 million for FY2024, which is 25199.43% up from last year.
  • As of Q3 2025, HealthLynked's Cash from Financing Activities stood at $435001.0, which was down 5052.47% from $415467.0 recorded in Q2 2025.
  • In the past 5 years, HealthLynked's Cash from Financing Activities registered a high of $4.4 million during Q1 2021, and its lowest value of -$7700.0 during Q4 2021.
  • Its 5-year average for Cash from Financing Activities is $815475.0, with a median of $435001.0 in 2025.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 10900.66% in 2021, then skyrocketed by 664684.42% in 2022.
  • Quarter analysis of 5 years shows HealthLynked's Cash from Financing Activities stood at -$7700.0 in 2021, then skyrocketed by 6646.84% to $504107.0 in 2022, then crashed by 59.94% to $201957.0 in 2023, then skyrocketed by 88.1% to $379885.0 in 2024, then increased by 14.51% to $435001.0 in 2025.
  • Its Cash from Financing Activities stands at $435001.0 for Q3 2025, versus $415467.0 for Q2 2025 and $378582.0 for Q1 2025.